It has been shown in studies of pancreatic ductal adenocarcinoma (PDAC) that upregulation of PLAU is directly linked to signaling pathways mediating interactions between pancreatic stellate cells (PSC) and cancer cells and is linked to an aggressive base/squamous phenotype of PDAC, which significantly reduces patient survival24. The gene discussed is PLAU; the disease is cancer.